Seeking Alpha

Chris Weale

View as an RSS Feed
  • Biotech Is Not A Popping Bubble: Buy The Dip While You Can
    Mon, Apr. 21 ALXN, AMGN, BIIB 15 Comments

    Summary

    • Biotechnology indices were overbought and needed a correction.
    • Short-term prices are particularly sensitive to sentiment.
    • The biotech industry is not overvalued; its growth and profitability warrants sustained premium valuations.
    • The correction should be over soon and you should buy the dip while you can.
  • It's Time To Reconsider Your Portfolio Strategy
    Editors' Pick • Jul. 18, 2013 64 Comments